XML 19 R5.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Reconciliation of net income to cash used by operating activities:    
Net income $ 5,416 $ 6,210
Add (deduct):    
Depreciation and amortization 15,322 15,384
Adjustments for bad debt provisions 922 818
Net realized and unrealized gains (3,053) (7,038)
Amortization of net discount on debt securities investments (527) (9)
Payments for title losses in excess of provisions (1,337) (5,432)
Adjustments for insurance recoveries of title losses 0 208
Increase in receivables – net (15,226) (12,674)
Increase in other assets – net (16,619) (5,582)
Decrease in accounts payable and other liabilities – net (18,737) (24,444)
Change in net deferred income taxes (24) (5)
Net (income) loss from equity method investments (269) 10
Dividends received from equity method investments 585 229
Stock-based compensation expense 3,488 2,670
Other – net 132 67
Cash used by operating activities (29,927) (29,588)
Investing activities:    
Proceeds from sales of investments in securities 16,009 20,874
Proceeds from matured investments in debt securities 11,864 6,646
Purchases of investments in securities (22,377) (23,677)
Net purchases of short-term investments (4,275) (4,927)
Purchases of property and equipment and other long-lived assets (12,314) (10,218)
Proceeds from sale of property and equipment and other assets 1,537 8
Cash paid for acquisition of businesses and related assets (7,424) 0
Increase in notes receivable (2,500) (6,320)
Purchases of cost-basis and other investments (909) (29,939)
Other – net 382 176
Cash used by investing activities (20,007) (47,377)
Financing activities:    
Proceeds from notes payable 995 3,387
Payments on notes payable (1,115) (3,378)
Distributions to noncontrolling interests (3,850) (3,720)
Repurchases of Common Stock (3,365) (3,390)
Proceeds from stock option and employee stock purchase plan exercises 2,897 3,583
Cash dividends paid (13,942) (13,067)
Payment of contingent consideration related to acquisitions (265) (186)
Cash used by financing activities (18,645) (16,771)
Effects of changes in foreign currency exchange rates 791 (1,278)
Change in cash and cash equivalents (67,788) (95,014)
Cash and cash equivalents at beginning of period 216,298 233,365
Cash and cash equivalents at end of period $ 148,510 $ 138,351